Oppenheimer & Co. Inc. Announces 34th Annual Healthcare Life Sciences Conference

Stock Information for Oppenheimer Holdings Inc. Class A (DE)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Oppenheimer Holdings Inc. Class A (DE)

Oppenheimer Holdings Inc. Reports First Quarter 2024 Earnings
Oppenheimer & Co. Inc. Appoints William Bird Director of Equity Research
Oppenheimer Further Expands Public Finance Banking Team with Appointment of Frank Sanchez Reed As Head of the Southwest Region
Oppenheimer Holdings Inc. Announces Share Repurchase Program
Oppenheimer Further Expands Public Finance Banking Team with Appointments of Kristin Stephens and David Moffett
Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2023 Earnings
Oppenheimer Names Elizabeth Coolidge Head of Public Finance
Oppenheimer Appoints Richard Jasen As Head of Technology & Consumer Private Capital

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.